Covid-19 Impact on Global Gastrointestinal Stromal Tumor (GIST) Drug Industry Research Report 2020 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2026
The research team projects that the Gastrointestinal Stromal Tumor (GIST) Drug market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Ariad Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Astex Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Calithera Biosciences, Inc.
Array BioPharma Inc.
F. Hoffmann-La Roche Ltd.
Boston Biomedical, Inc.
Blueprint Medicines Corporation
Deciphera Pharmaceuticals, LLC
Natco Pharma Limited
Omeros Corporation
Horizon Pharma Plc
Nerviano Medical Sciences S.r.l.
Kolltan Pharmaceuticals, Inc.
Immunicum AB
Novartis AG
Jiangsu Hengrui Medicine Co., Ltd.
By Type
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
By Application
Clinic
Hospital
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Gastrointestinal Stromal Tumor (GIST) Drug 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Gastrointestinal Stromal Tumor (GIST) Drug Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Gastrointestinal Stromal Tumor (GIST) Drug Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gastrointestinal Stromal Tumor (GIST) Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Ariad Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Astex Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Calithera Biosciences, Inc.
Array BioPharma Inc.
F. Hoffmann-La Roche Ltd.
Boston Biomedical, Inc.
Blueprint Medicines Corporation
Deciphera Pharmaceuticals, LLC
Natco Pharma Limited
Omeros Corporation
Horizon Pharma Plc
Nerviano Medical Sciences S.r.l.
Kolltan Pharmaceuticals, Inc.
Immunicum AB
Novartis AG
Jiangsu Hengrui Medicine Co., Ltd.
By Type
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
By Application
Clinic
Hospital
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Gastrointestinal Stromal Tumor (GIST) Drug 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Gastrointestinal Stromal Tumor (GIST) Drug Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Gastrointestinal Stromal Tumor (GIST) Drug Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gastrointestinal Stromal Tumor (GIST) Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Gastrointestinal Stromal Tumor (GIST) Drug Revenue
1.5 Market Analysis by Type
1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type: 2020 VS 2026
1.5.2 Amcasertib
1.5.3 Anagrelide hydrochloride CR
1.5.4 APG-1351
1.5.5 Binimetinib
1.5.6 Others
1.6 Market by Application
1.6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application: 2021-2026
1.6.2 Clinic
1.6.3 Hospital
1.6.4 Others
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET TRENDS AND GROWTH STRATEGY
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter’s Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET PLAYERS PROFILES
3.1 Ariad Pharmaceuticals, Inc.
3.1.1 Ariad Pharmaceuticals, Inc. Company Profile
3.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.2 Chipscreen Biosciences Ltd
3.2.1 Chipscreen Biosciences Ltd Company Profile
3.2.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.2.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.3 Astex Pharmaceuticals, Inc.
3.3.1 Astex Pharmaceuticals, Inc. Company Profile
3.3.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.3.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 Arog Pharmaceuticals, Inc.
3.4.1 Arog Pharmaceuticals, Inc. Company Profile
3.4.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.4.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Calithera Biosciences, Inc.
3.5.1 Calithera Biosciences, Inc. Company Profile
3.5.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.5.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 Array BioPharma Inc.
3.6.1 Array BioPharma Inc. Company Profile
3.6.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.6.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 F. Hoffmann-La Roche Ltd.
3.7.1 F. Hoffmann-La Roche Ltd. Company Profile
3.7.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.7.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Boston Biomedical, Inc.
3.8.1 Boston Biomedical, Inc. Company Profile
3.8.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.8.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Blueprint Medicines Corporation
3.9.1 Blueprint Medicines Corporation Company Profile
3.9.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.9.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Deciphera Pharmaceuticals, LLC
3.10.1 Deciphera Pharmaceuticals, LLC Company Profile
3.10.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.10.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 Natco Pharma Limited
3.11.1 Natco Pharma Limited Company Profile
3.11.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.11.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Omeros Corporation
3.12.1 Omeros Corporation Company Profile
3.12.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.12.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.13 Horizon Pharma Plc
3.13.1 Horizon Pharma Plc Company Profile
3.13.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.13.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.14 Nerviano Medical Sciences S.r.l.
3.14.1 Nerviano Medical Sciences S.r.l. Company Profile
3.14.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.14.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.15 Kolltan Pharmaceuticals, Inc.
3.15.1 Kolltan Pharmaceuticals, Inc. Company Profile
3.15.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.15.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.16 Immunicum AB
3.16.1 Immunicum AB Company Profile
3.16.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.16.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.17 Novartis AG
3.17.1 Novartis AG Company Profile
3.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.18 Jiangsu Hengrui Medicine Co., Ltd.
3.18.1 Jiangsu Hengrui Medicine Co., Ltd. Company Profile
3.18.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.18.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITION BY MARKET PLAYERS
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity Market Share by Market Players (2015-2020)
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Market Players (2015-2020)
4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Market Players (2015-2020)
5 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG PRODUCTION BY REGIONS (2015-2020)
5.1 North America
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in North America (2015-2020)
5.1.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.1.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.2 East Asia
5.2.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in East Asia (2015-2020)
5.2.3 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.2.4 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.3 Europe
5.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Europe (2015-2020)
5.3.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.3.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.4 South Asia
5.4.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in South Asia (2015-2020)
5.4.3 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.4.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.5 Southeast Asia
5.5.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Southeast Asia (2015-2020)
5.5.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.5.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.6 Middle East
5.6.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Middle East (2015-2020)
5.6.3 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.6.4 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.7 Africa
5.7.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Africa (2015-2020)
5.7.3 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.7.4 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.8 Oceania
5.8.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Oceania (2015-2020)
5.8.3 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.8.4 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.9 South America
5.9.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in South America (2015-2020)
5.9.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.9.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.10 Rest of the World
5.10.1 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Rest of the World (2015-2020)
5.10.3 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.10.4 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
6 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG CONSUMPTION BY REGION (2015-2020)
6.1 North America
6.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
7 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG PRODUCTION FORECAST BY REGIONS (2021-2026)
7.1 Global Forecasted Production of Gastrointestinal Stromal Tumor (GIST) Drug (2021-2026)
7.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug (2021-2026)
7.3 Global Forecasted Price of Gastrointestinal Stromal Tumor (GIST) Drug (2021-2026)
7.4 Global Forecasted Production of Gastrointestinal Stromal Tumor (GIST) Drug by Region (2021-2026)
7.4.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.2 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.6 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.7 Africa Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.8 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.10 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.5 Forecast by Type and by Application (2021-2026)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
7.5.2 Global Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2021-2026)
8 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG CONSUMPTION FORECAST BY REGIONS (2021-2026)
8.1 North America Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.2 East Asia Market Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.3 Europe Market Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Countriy
8.4 South Asia Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.5 Southeast Asia Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.6 Middle East Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.7 Africa Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.8 Oceania Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.9 South America Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.10 Rest of the world Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
9 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG SALES BY TYPE (2015-2026)
9.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Type (2015-2020)
9.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Type (2021-2026)
10 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG CONSUMPTION BY APPLICATION (2015-2026)
10.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Application (2015-2020)
10.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Application (2021-2026)
11 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MANUFACTURING COST ANALYSIS
11.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
12 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKETING CHANNEL, DISTRIBUTORS, CUSTOMERS AND SUPPLY CHAIN
12.1 Marketing Channel
12.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
12.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers
12.4 Gastrointestinal Stromal Tumor (GIST) Drug Supply Chain Analysis
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 DISCLAIMER
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Gastrointestinal Stromal Tumor (GIST) Drug Revenue
1.5 Market Analysis by Type
1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type: 2020 VS 2026
1.5.2 Amcasertib
1.5.3 Anagrelide hydrochloride CR
1.5.4 APG-1351
1.5.5 Binimetinib
1.5.6 Others
1.6 Market by Application
1.6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application: 2021-2026
1.6.2 Clinic
1.6.3 Hospital
1.6.4 Others
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET TRENDS AND GROWTH STRATEGY
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter’s Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET PLAYERS PROFILES
3.1 Ariad Pharmaceuticals, Inc.
3.1.1 Ariad Pharmaceuticals, Inc. Company Profile
3.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.2 Chipscreen Biosciences Ltd
3.2.1 Chipscreen Biosciences Ltd Company Profile
3.2.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.2.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.3 Astex Pharmaceuticals, Inc.
3.3.1 Astex Pharmaceuticals, Inc. Company Profile
3.3.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.3.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 Arog Pharmaceuticals, Inc.
3.4.1 Arog Pharmaceuticals, Inc. Company Profile
3.4.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.4.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Calithera Biosciences, Inc.
3.5.1 Calithera Biosciences, Inc. Company Profile
3.5.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.5.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 Array BioPharma Inc.
3.6.1 Array BioPharma Inc. Company Profile
3.6.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.6.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 F. Hoffmann-La Roche Ltd.
3.7.1 F. Hoffmann-La Roche Ltd. Company Profile
3.7.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.7.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Boston Biomedical, Inc.
3.8.1 Boston Biomedical, Inc. Company Profile
3.8.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.8.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Blueprint Medicines Corporation
3.9.1 Blueprint Medicines Corporation Company Profile
3.9.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.9.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Deciphera Pharmaceuticals, LLC
3.10.1 Deciphera Pharmaceuticals, LLC Company Profile
3.10.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.10.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 Natco Pharma Limited
3.11.1 Natco Pharma Limited Company Profile
3.11.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.11.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Omeros Corporation
3.12.1 Omeros Corporation Company Profile
3.12.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.12.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.13 Horizon Pharma Plc
3.13.1 Horizon Pharma Plc Company Profile
3.13.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.13.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.14 Nerviano Medical Sciences S.r.l.
3.14.1 Nerviano Medical Sciences S.r.l. Company Profile
3.14.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.14.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.15 Kolltan Pharmaceuticals, Inc.
3.15.1 Kolltan Pharmaceuticals, Inc. Company Profile
3.15.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.15.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.16 Immunicum AB
3.16.1 Immunicum AB Company Profile
3.16.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.16.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.17 Novartis AG
3.17.1 Novartis AG Company Profile
3.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.18 Jiangsu Hengrui Medicine Co., Ltd.
3.18.1 Jiangsu Hengrui Medicine Co., Ltd. Company Profile
3.18.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
3.18.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITION BY MARKET PLAYERS
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity Market Share by Market Players (2015-2020)
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Market Players (2015-2020)
4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Market Players (2015-2020)
5 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG PRODUCTION BY REGIONS (2015-2020)
5.1 North America
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in North America (2015-2020)
5.1.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.1.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.2 East Asia
5.2.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in East Asia (2015-2020)
5.2.3 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.2.4 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.3 Europe
5.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Europe (2015-2020)
5.3.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.3.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.4 South Asia
5.4.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in South Asia (2015-2020)
5.4.3 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.4.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.5 Southeast Asia
5.5.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Southeast Asia (2015-2020)
5.5.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.5.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.6 Middle East
5.6.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Middle East (2015-2020)
5.6.3 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.6.4 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.7 Africa
5.7.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Africa (2015-2020)
5.7.3 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.7.4 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.8 Oceania
5.8.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Oceania (2015-2020)
5.8.3 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.8.4 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.9 South America
5.9.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in South America (2015-2020)
5.9.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.9.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
5.10 Rest of the World
5.10.1 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2015-2020)
5.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Rest of the World (2015-2020)
5.10.3 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020)
5.10.4 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020)
6 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG CONSUMPTION BY REGION (2015-2020)
6.1 North America
6.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
7 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG PRODUCTION FORECAST BY REGIONS (2021-2026)
7.1 Global Forecasted Production of Gastrointestinal Stromal Tumor (GIST) Drug (2021-2026)
7.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug (2021-2026)
7.3 Global Forecasted Price of Gastrointestinal Stromal Tumor (GIST) Drug (2021-2026)
7.4 Global Forecasted Production of Gastrointestinal Stromal Tumor (GIST) Drug by Region (2021-2026)
7.4.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.2 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.6 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.7 Africa Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.8 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.4.10 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2021-2026)
7.5 Forecast by Type and by Application (2021-2026)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
7.5.2 Global Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2021-2026)
8 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG CONSUMPTION FORECAST BY REGIONS (2021-2026)
8.1 North America Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.2 East Asia Market Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.3 Europe Market Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Countriy
8.4 South Asia Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.5 Southeast Asia Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.6 Middle East Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.7 Africa Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.8 Oceania Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.9 South America Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.10 Rest of the world Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
9 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG SALES BY TYPE (2015-2026)
9.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Type (2015-2020)
9.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Type (2021-2026)
10 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG CONSUMPTION BY APPLICATION (2015-2026)
10.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Application (2015-2020)
10.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Application (2021-2026)
11 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MANUFACTURING COST ANALYSIS
11.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
12 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKETING CHANNEL, DISTRIBUTORS, CUSTOMERS AND SUPPLY CHAIN
12.1 Marketing Channel
12.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
12.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers
12.4 Gastrointestinal Stromal Tumor (GIST) Drug Supply Chain Analysis
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 DISCLAIMER
LIST OF TABLES AND FIGURES
Table 1. Research Programs/Design for This Report
Table 2. Key Data Information from Secondary Sources
Table 3. Key Executives Interviewed
Table 4. Key Data Information from Primary Sources
Table 5. Key Players Covered: Ranking by Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) 2015-2020
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (US$ Million): 2021-2026
Table 7. Amcasertib Features
Table 8. Anagrelide hydrochloride CR Features
Table 9. APG-1351 Features
Table 10. Binimetinib Features
Table 11. Others Features
Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (US$ Million): 2021-2026
Table 17. Clinic Case Studies
Table 18. Hospital Case Studies
Table 19. Others Case Studies
Table 26. Overview of the World Economic Outlook Projections
Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 32. Commodity Prices-Metals Price Indices
Table 33. Commodity Prices- Precious Metal Price Indices
Table 34. Commodity Prices- Agricultural Raw Material Price Indices
Table 35. Commodity Prices- Food and Beverage Price Indices
Table 36. Commodity Prices- Fertilizer Price Indices
Table 37. Commodity Prices- Energy Price Indices
Table 38. G20+: Economic Policy Responses to COVID-19
Table 39. Covid-19 Impact: Global Major Government Policy
Table 40. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
Table 41. Market Top Trends
Table 42. Key Drivers: Impact Analysis
Table 43. Key Challenges
Table 44. Porter's Five Forces Analysis
Table 45. Gastrointestinal Stromal Tumor (GIST) Drug Market Growth Strategy
Table 46. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
Table 47. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 48. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 49. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 50. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 51. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 52. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 53. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 54. Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 55. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 56. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 57. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 58. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 59. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 60. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 61. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 62. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 63. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 64. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 65. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 66. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 67. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 68. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 69. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 70. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 71. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 72. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 73. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 74. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 75. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 76. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 77. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 78. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 79. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 80. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 81. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 82. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 147. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity by Market Players
Table 148. Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Market Players (2015-2020)
Table 149. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Market Players (2015-2020)
Table 150. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Market Players (2015-2020)
Table 151. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Market Players (2015-2020)
Table 152. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price of Key Market Players (2015-2020)
Table 153. North America Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 154. North America Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 155. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 156. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 157. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 158. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 159. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 160. East Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 161. East Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 162. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 163. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 164. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 165. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 166. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 167. Europe Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 168. Europe Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 169. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 170. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 171. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 172. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 173. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 174. South Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 175. South Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 176. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 177. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 178. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 179. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 180. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 181. Southeast Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 182. Southeast Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 183. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 184. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 185. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 186. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 187. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 188. Middle East Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 189. Middle East Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 190. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 191. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 192. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 193. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 194. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 195. Africa Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 196. Africa Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 197. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 198. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 199. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 200. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 201. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 202. Oceania Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 203. Oceania Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 204. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 205. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 206. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 207. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 208. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 209. South America Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 210. South America Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 211. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 212. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 213. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 214. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 215. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 216. Rest of the World Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 217. Rest of the World Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 218. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 219. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 220. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 221. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 222. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 223. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 224. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region (2015-2020)
Table 225. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 226. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 227. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 228. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 229. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 230. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 231. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 232. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Forecast by Region (2021-2026)
Table 233. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Forecast by Type (2021-2026)
Table 234. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Market Share Forecast by Type (2021-2026)
Table 235. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Revenue Forecast by Type (2021-2026)
Table 236. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Revenue Market Share Forecast by Type (2021-2026)
Table 237. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Forecast by Type (2021-2026)
Table 238. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume Forecast by Application (2021-2026)
Table 239. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Forecast by Application (2021-2026)
Table 240. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 241. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 242. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 243. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 244. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 245. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 246. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 247. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 248. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 249. Rest of the world Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 250. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 251. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2015-2020)
Table 252. Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 253. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2021-2026)
Table 254. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 255. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2015-2020)
Table 256. Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 257. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2021-2026)
Table 258. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 259. Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Figure 1. Product Figure
Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type: 2020 VS 2026
Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application: 2020 VS 2026
Figure 4. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Figure 5. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 6. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 7. United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 8. Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 9. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 10. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 11. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 12. China Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 13. Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 14. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 15. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 16. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Region in 2020
Figure 17. Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 18. United Kingdom Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 19. France Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 20. Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 21. Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 22. Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 23. Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 24. Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 25. Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 26. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 27. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 28. India Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 29. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 30. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 31. Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 32. Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 33. Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 34. Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 35. Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 37. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 38. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 40. Iran Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 42. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 43. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 44. Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 45. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 46. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 47. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 48. Australia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 49. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 50. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 51. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 52. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 53. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 54. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 55. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity Growth Rate Forecast (2021-2026)
Figure 56. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 57. Global Gastrointestinal Stromal Tumor (GIST) Drug Price and Trend Forecast (2021-2026)
Figure 58. North America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 59. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 60. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 61. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 62. Europe Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 63. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 64. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 65. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 66. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 67. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 68. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 69. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 70. Africa Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 71. Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 72. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 73. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 74. South America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 75. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 76. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 77. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 78. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 79. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 80. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 81. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 82. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 83. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 84. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 85. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 86. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 87. Rest of the world Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 88. Manufacturing Cost Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 89. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Gastrointestinal Stromal Tumor (GIST) Drug Supply Chain Analysis
Table 1. Research Programs/Design for This Report
Table 2. Key Data Information from Secondary Sources
Table 3. Key Executives Interviewed
Table 4. Key Data Information from Primary Sources
Table 5. Key Players Covered: Ranking by Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) 2015-2020
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (US$ Million): 2021-2026
Table 7. Amcasertib Features
Table 8. Anagrelide hydrochloride CR Features
Table 9. APG-1351 Features
Table 10. Binimetinib Features
Table 11. Others Features
Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (US$ Million): 2021-2026
Table 17. Clinic Case Studies
Table 18. Hospital Case Studies
Table 19. Others Case Studies
Table 26. Overview of the World Economic Outlook Projections
Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 32. Commodity Prices-Metals Price Indices
Table 33. Commodity Prices- Precious Metal Price Indices
Table 34. Commodity Prices- Agricultural Raw Material Price Indices
Table 35. Commodity Prices- Food and Beverage Price Indices
Table 36. Commodity Prices- Fertilizer Price Indices
Table 37. Commodity Prices- Energy Price Indices
Table 38. G20+: Economic Policy Responses to COVID-19
Table 39. Covid-19 Impact: Global Major Government Policy
Table 40. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
Table 41. Market Top Trends
Table 42. Key Drivers: Impact Analysis
Table 43. Key Challenges
Table 44. Porter's Five Forces Analysis
Table 45. Gastrointestinal Stromal Tumor (GIST) Drug Market Growth Strategy
Table 46. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
Table 47. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 48. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 49. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 50. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 51. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 52. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 53. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 54. Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 55. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 56. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 57. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 58. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 59. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 60. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 61. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 62. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 63. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 64. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 65. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 66. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 67. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 68. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 69. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 70. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 71. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 72. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 73. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 74. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 75. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 76. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 77. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 78. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 79. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 80. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 81. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 82. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
Table 147. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity by Market Players
Table 148. Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Market Players (2015-2020)
Table 149. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Market Players (2015-2020)
Table 150. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Market Players (2015-2020)
Table 151. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Market Players (2015-2020)
Table 152. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price of Key Market Players (2015-2020)
Table 153. North America Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 154. North America Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 155. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 156. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 157. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 158. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 159. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 160. East Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 161. East Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 162. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 163. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 164. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 165. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 166. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 167. Europe Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 168. Europe Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 169. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 170. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 171. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 172. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 173. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 174. South Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 175. South Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 176. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 177. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 178. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 179. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 180. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 181. Southeast Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 182. Southeast Asia Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 183. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 184. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 185. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 186. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 187. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 188. Middle East Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 189. Middle East Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 190. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 191. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 192. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 193. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 194. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 195. Africa Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 196. Africa Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 197. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 198. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 199. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 200. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 201. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 202. Oceania Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 203. Oceania Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 204. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 205. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 206. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 207. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 208. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 209. South America Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 210. South America Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 211. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 212. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 213. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 214. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 215. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Table 216. Rest of the World Key Players Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2015-2020) (US$ Million)
Table 217. Rest of the World Key Players Gastrointestinal Stromal Tumor (GIST) Drug Market Share (2015-2020)
Table 218. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 219. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type (2015-2020)
Table 220. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 221. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2015-2020)
Table 222. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 223. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 224. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region (2015-2020)
Table 225. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 226. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 227. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 228. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 229. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 230. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 231. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2015-2020)
Table 232. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Forecast by Region (2021-2026)
Table 233. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Forecast by Type (2021-2026)
Table 234. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Market Share Forecast by Type (2021-2026)
Table 235. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Revenue Forecast by Type (2021-2026)
Table 236. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Revenue Market Share Forecast by Type (2021-2026)
Table 237. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Forecast by Type (2021-2026)
Table 238. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume Forecast by Application (2021-2026)
Table 239. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Forecast by Application (2021-2026)
Table 240. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 241. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 242. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 243. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 244. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 245. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 246. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 247. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 248. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 249. Rest of the world Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026 by Country
Table 250. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2015-2020) (US$ Million)
Table 251. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2015-2020)
Table 252. Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 253. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2021-2026)
Table 254. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2015-2020) (US$ Million)
Table 255. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2015-2020)
Table 256. Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 257. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2021-2026)
Table 258. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 259. Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Figure 1. Product Figure
Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type: 2020 VS 2026
Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application: 2020 VS 2026
Figure 4. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2015-2020) (US$ Million)
Figure 5. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 6. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 7. United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 8. Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 9. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 10. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 11. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 12. China Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 13. Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 14. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 15. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 16. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Region in 2020
Figure 17. Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 18. United Kingdom Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 19. France Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 20. Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 21. Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 22. Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 23. Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 24. Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 25. Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 26. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 27. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 28. India Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 29. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 30. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 31. Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 32. Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 33. Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 34. Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 35. Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 37. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 38. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 40. Iran Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 42. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 43. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 44. Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 45. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 46. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 47. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 48. Australia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 49. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 50. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 51. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 52. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2015-2020)
Figure 53. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 54. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2020
Figure 55. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity Growth Rate Forecast (2021-2026)
Figure 56. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 57. Global Gastrointestinal Stromal Tumor (GIST) Drug Price and Trend Forecast (2021-2026)
Figure 58. North America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 59. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 60. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 61. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 62. Europe Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 63. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 64. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 65. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 66. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 67. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 68. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 69. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 70. Africa Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 71. Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 72. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 73. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 74. South America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 75. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 76. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2021-2026)
Figure 77. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2021-2026)
Figure 78. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 79. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 80. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 81. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 82. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 83. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 84. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 85. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 86. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 87. Rest of the world Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2021-2026
Figure 88. Manufacturing Cost Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 89. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Gastrointestinal Stromal Tumor (GIST) Drug Supply Chain Analysis
